$332 Million is the total value of Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s 19 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 9.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FCX | Buy | FREEPORT-MCMORAN INCcl b | $76,648,662 | +28.4% | 1,836,776 | +0.1% | 23.12% | +35.1% |
GM | Buy | GENERAL MTRS CO | $32,630,937 | +11.6% | 556,557 | +0.3% | 9.84% | +17.4% |
FISV | Buy | FISERV INC | $28,389,056 | -4.0% | 273,524 | +0.3% | 8.56% | +1.0% |
GOOG | ALPHABET INCcap stk cl c | $28,270,374 | +8.6% | 9,770 | 0.0% | 8.53% | +14.2% | |
TJX | Buy | TJX COS INC NEW | $21,942,247 | +15.9% | 289,018 | +0.7% | 6.62% | +21.9% |
PYPL | PAYPAL HLDGS INC | $21,120,960 | -27.5% | 112,000 | 0.0% | 6.37% | -23.8% | |
KOD | Buy | KODIAK SCIENCES INC | $17,193,638 | -11.3% | 202,803 | +0.5% | 5.19% | -6.6% |
JKHY | Buy | HENRY JACK & ASSOC INC | $14,956,459 | +2.9% | 89,565 | +1.1% | 4.51% | +8.3% |
SAGE | Buy | SAGE THERAPEUTICS INC | $13,812,398 | -3.5% | 324,692 | +0.5% | 4.17% | +1.5% |
BURL | Buy | BURLINGTON STORES INC | $12,029,160 | +3.2% | 41,265 | +0.4% | 3.63% | +8.5% |
VFC | Buy | V F CORP | $11,839,674 | +9.8% | 161,700 | +0.5% | 3.57% | +15.5% |
ROST | Buy | ROSS STORES INC | $11,711,757 | +5.6% | 102,483 | +0.6% | 3.53% | +11.1% |
PSN | Buy | PARSONS CORP DEL | $9,105,354 | +0.4% | 270,590 | +0.7% | 2.75% | +5.6% |
SCPL | SCIPLAY CORPORATIONcl a | $8,819,200 | -33.4% | 640,000 | 0.0% | 2.66% | -29.9% | |
LPSN | Buy | LIVEPERSON INC | $8,066,683 | -38.5% | 225,831 | +1.5% | 2.43% | -35.3% |
ALK | Buy | ALASKA AIR GROUP INC | $3,868,998 | -10.4% | 74,261 | +0.8% | 1.17% | -5.7% |
LUV | Buy | SOUTHWEST AIRLS CO | $3,827,111 | -16.1% | 89,335 | +0.8% | 1.15% | -11.7% |
NCLH | Buy | NORWEGIAN CRUISE LINE HLDG L | $3,649,199 | -21.9% | 175,865 | +0.6% | 1.10% | -17.8% |
JBLU | Buy | JETBLUE AWYS CORP | $3,639,473 | -6.1% | 255,581 | +0.9% | 1.10% | -1.2% |
CAR | Exit | AVIS BUDGET GROUP | $0 | – | -81,645 | -100.0% | -2.73% | – |
DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -353,877 | -100.0% | -3.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-17
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FREEPORT-MCMORAN INC | 19 | Q2 2024 | 27.7% |
ALPHABET INC | 17 | Q2 2024 | 20.3% |
PARSONS CORPORATION | 15 | Q2 2024 | 6.5% |
TJX COS INC NEW | 14 | Q2 2024 | 9.6% |
GENERAL MTRS CO | 14 | Q2 2024 | 10.8% |
FISERV INC | 12 | Q2 2024 | 8.6% |
PAYPAL HLDGS INC | 11 | Q2 2022 | 12.0% |
JPMORGAN CHASE & CO | 10 | Q2 2024 | 8.5% |
SAGE THERAPEUTICS INC | 9 | Q4 2021 | 12.2% |
DECIPHERA PHARMACEUTICALS IN | 8 | Q3 2021 | 15.3% |
View Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-27 |
13F-HR | 2024-07-19 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
View Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.